{"id":1158,"date":"2017-03-13T07:21:19","date_gmt":"2017-03-13T11:21:19","guid":{"rendered":"https:\/\/www.stockcalc.com\/blog\/BrianD\/?p=1158"},"modified":"2017-03-13T07:21:19","modified_gmt":"2017-03-13T11:21:19","slug":"calithera-biosciences-calanas-and-zosano-pharma-zsannas-are-biggest-stock-gainers-ytd-on-nasdaq","status":"publish","type":"post","link":"https:\/\/www.stockcalc.com\/blog\/BrianD\/2017\/03\/13\/calithera-biosciences-calanas-and-zosano-pharma-zsannas-are-biggest-stock-gainers-ytd-on-nasdaq\/","title":{"rendered":"Calithera Biosciences (CALA:NAS) and Zosano Pharma (ZSAN:NAS) Are Biggest Stock Gainers YTD on NASDAQ"},"content":{"rendered":"<p style=\"text-align:justify;\">I have used the analysis tools on the website <a href=\"https:\/\/www.stockcalc.com\/\">stockcalc.com<\/a> to generate some of the content of this blog post. These tools and reports are available for free at <a href=\"https:\/\/www.stockcalc.com\/TopPicks.aspx\">www.stockcalc.com\/TopPicks.aspx<\/a>.<\/p>\n<h4>Biggest Stock Gainers Year to Date on NASDAQ<\/h4>\n<p style=\"text-align:justify;\">Today we are looking at companies that have had the greatest percentage increase in share price year to date.<\/p>\n<h5>Top 25 Companies<\/h5>\n<p style=\"text-align:justify;\">Lists like these are always interesting to look at as they tell more than one story. Companies that are experiencing dramatic increases in share price can do so for a variety of reasons. These can include, the sector they are in has turned (such as companies in the commodities space or a new sector that has huge future potential), the company is in talks to be taken over, or the company has restructured and earnings are turning better than expected.<\/p>\n<p style=\"text-align:justify;\">In this list we have selected the top 25 companies based on their percentage increase in share price year to date.<\/p>\n<h4>Today&#8217;s Data on NASDAQ<\/h4>\n<p style=\"text-align:justify;\">Today&#8217;s data is for companies listed on the <strong>NASDAQ<\/strong>.<\/p>\n<table style=\"font-size:11px;font-family:Lato,sans-serif;\">\n<tr>\n<th style=\"background-color:#6e8295;text-align:center;padding:0.5em;border:1px solid white;color:white;\">Symbol<\/th>\n<th style=\"background-color:#6e8295;text-align:center;padding:0.5em;border:1px solid white;color:white;\">Name<\/th>\n<th style=\"background-color:#6e8295;text-align:center;padding:0.5em;border:1px solid white;color:white;\">Total Return<\/th>\n<th style=\"background-color:#6e8295;text-align:center;padding:0.5em;border:1px solid white;color:white;\">Period<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">PULM<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Pulmatrix Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">566.101695<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">LPTX<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Leap Therapeutics Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">462.924678<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">CALA<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Calithera Biosciences Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">281.538462<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">ZSAN<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Zosano Pharma Corp<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">253.846154<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">MGEN<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Miragen Therapeutics Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">227.145709<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">ETRM<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">EnteroMedics Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">217.000000<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">BIOC<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Biocept Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">198.064516<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">PME<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Pingtan Marine Enterprise Ltd<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">177.586207<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">BLPH<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Bellerophon Therapeutics Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">169.127259<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">MYOS<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Myos Rens Technology Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">151.694915<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">ESPR<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Esperion Therapeutics Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">149.600639<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">OREX<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Orexigen Therapeutics Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">147.701149<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">AUPH<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Aurinia Pharmaceuticals Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">129.047619<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">PLSE<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Pulse Biosciences Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">128.923077<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">AAOI<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Applied Optoelectronics Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">127.474403<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">SGLB<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Sigma Labs Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">116.049383<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">NAKD<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Naked Brand Group Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">110.000000<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">SBLK<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Star Bulk Carriers Corp.<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">109.589041<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">IOTS<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Adesto Technologies Corp<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">105.405405<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">CBAY<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">CymaBay Therapeutics Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">102.890173<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">NBRV<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Nabriva Therapeutics AG<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">101.342282<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">NLNK<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">NewLink Genetics Corp<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">98.832685<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">AKAO<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Achaogen Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">96.159754<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr style=\"background-color:rgba(0,0,0,0.05);\">\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">DELT<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Delta Technology Holdings Ltd<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">95.890411<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">CERU<\/td>\n<td style=\"padding:0.24em; text-align:left; border:1px solid white;\">Cerulean Pharma Inc<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">94.860209<\/td>\n<td style=\"padding:0.24em; text-align:right; border:1px solid white;\">YTD<\/td>\n<\/tr>\n<\/table>\n<h4>Let&#8217;s look at a few companies&#8230;<\/h4>\n<p style=\"text-align:justify;\">Lets look at a couple of the companies on this list to get a better understanding of them.<\/p>\n<h6 style=\"margin-bottom:0.5em;\">CALA:NAS Calithera Biosciences<\/h6>\n<p><a href=\"http:\/\/www.calithera.com\">http:\/\/www.calithera.com<\/a><br \/>\nCalithera Biosciences has 44 employees and is headquartered in United States.<br \/>\nCalithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.<\/p>\n<h6 style=\"margin-bottom:0.5em;\">ZSAN:NAS Zosano Pharma<\/h6>\n<p><a href=\"http:\/\/www.zosanopharma.com\">http:\/\/www.zosanopharma.com<\/a><br \/>\nZosano Pharma has 38 employees and is headquartered in United States.<br \/>\nZosano Pharma Corp is a clinical stage specialty pharmaceutical company. It develops a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of various indications.<\/p>\n<h4 style=\"background-color:rgba(0,0,0,0.05);margin-bottom:0;padding:0.75rem;padding-bottom:0;\">Free Valuation<\/h4>\n<p style=\"text-align:justify;background-color:rgba(0,0,0,0.05);padding:0.75rem;padding-top:0.25rem;\">Run a valuation on any of the companies listed above at <a href=\"https:\/\/www.stockcalc.com\/valureport.aspx\">www.stockcalc.com\/valureport.aspx<\/a> or subscribe at our Stockcalc Facebook Page to receive this list each day <a href=\"https:\/\/www.facebook.com\/stockcalc\/app\/100265896690345\">Stockcalc Reports<\/a>.<\/p>\n<p><em>The content presented here is in part from the website <a href=\"www.stockcalc.com\">stockcalc.com<\/a> and is provided on an <strong>as is<\/strong> or <strong>as available<\/strong> basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com\/TopPicks.aspx. Biggest Stock Gainers Year to Date on NASDAQ Today we are looking at companies that have had the greatest percentage increase in share price year &hellip; <a href=\"https:\/\/www.stockcalc.com\/blog\/BrianD\/2017\/03\/13\/calithera-biosciences-calanas-and-zosano-pharma-zsannas-are-biggest-stock-gainers-ytd-on-nasdaq\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Calithera Biosciences (CALA:NAS) and Zosano Pharma (ZSAN:NAS) Are Biggest Stock Gainers YTD on NASDAQ<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[970,971,969,968,974,975,41,966,967,61,60,973,972],"class_list":["post-1158","post","type-post","status-publish","format-standard","hentry","category-top-25-stock-gainers-year-to-date","tag-cala","tag-calithera-biosciences","tag-leap-therapeutics","tag-lptx","tag-mgen","tag-miragen-therapeutics","tag-nasdaq","tag-pulm","tag-pulmatrix","tag-rising-stocks","tag-stock-gainers","tag-zosano-pharma","tag-zsan"],"jetpack_featured_media_url":"","jetpack_likes_enabled":true,"jetpack-related-posts":[],"jetpack_shortlink":"https:\/\/wp.me\/p6Fvkg-iG","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/posts\/1158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/comments?post=1158"}],"version-history":[{"count":1,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/posts\/1158\/revisions"}],"predecessor-version":[{"id":1159,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/posts\/1158\/revisions\/1159"}],"wp:attachment":[{"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/media?parent=1158"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/categories?post=1158"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/tags?post=1158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}